Companies House 14997306 2025-07-31 2025-07-31 2024-08-01 false iso4217:GBP xbrli:pure 14997306 2023-07-12 2024-07-31 14997306 2025-07-31 14997306 2024-08-01 2025-07-31 14997306 2024-07-31 14997306 curr:PoundSterling 2024-08-01 2025-07-31 14997306 uk-bus:CompanyLimitedByGuarantee 2024-08-01 2025-07-31 14997306 uk-bus:FRS102 2024-08-01 2025-07-31 14997306 uk-bus:AuditExempt-NoAccountantsReport 2024-08-01 2025-07-31 14997306 uk-bus:FullAccounts 2024-08-01 2025-07-31 14997306 uk-bus:RegisteredOffice 2024-08-01 2025-07-31 14997306 uk-bus:Director1 2024-08-01 2025-07-31 14997306 uk-bus:Director2 2024-08-01 2025-07-31 14997306 uk-bus:Director3 2024-08-01 2025-07-31 14997306 uk-bus:Director4 2024-08-01 2025-07-31 14997306 uk-bus:Director5 2024-08-01 2025-07-31 14997306 uk-bus:Director6 2024-08-01 2025-07-31 14997306 uk-bus:Director7 2024-08-01 2025-07-31 14997306 uk-bus:Director8 2024-08-01 2025-07-31 14997306 uk-bus:Director9 2024-08-01 2025-07-31 14997306 uk-bus:Director10 2024-08-01 2025-07-31 14997306 uk-bus:Director11 2024-08-01 2025-07-31 14997306 uk-bus:Director12 2024-08-01 2025-07-31 14997306 uk-bus:Director13 2024-08-01 2025-07-31 14997306 uk-bus:Director14 2024-08-01 2025-07-31 14997306 uk-bus:Director15 2024-08-01 2025-07-31 14997306 uk-bus:Director16 2024-08-01 2025-07-31 14997306 uk-bus:Director17 2024-08-01 2025-07-31 14997306 uk-bus:Director18 2024-08-01 2025-07-31 14997306 uk-bus:Director19 2024-08-01 2025-07-31 14997306 uk-bus:Director20 2024-08-01 2025-07-31 14997306 uk-bus:Director21 2024-08-01 2025-07-31 14997306 uk-bus:CompanySecretary1 2024-08-01 2025-07-31 14997306 core:AfterOneYear 2025-07-31 14997306 core:AfterOneYear 2024-07-31 14997306 core:WithinOneYear 2025-07-31 14997306 core:WithinOneYear 2024-07-31 14997306 core:WithinOneYear 2024-08-01 2025-07-31 14997306 core:AfterOneYear 2025-07-31 14997306 core:AfterOneYear 2024-07-31 14997306 core:AfterOneYear 2024-08-01 2025-07-31 14997306 core:ShareCapital 2025-07-31 14997306 core:ShareCapital 2024-07-31 14997306 core:SharePremium 2025-07-31 14997306 core:SharePremium 2024-07-31 14997306 core:OtherReservesSubtotal 2025-07-31 14997306 core:OtherReservesSubtotal 2024-07-31 14997306 core:RevaluationReserve 2025-07-31 14997306 core:RevaluationReserve 2024-07-31 14997306 core:RetainedEarningsAccumulatedLosses 2025-07-31 14997306 core:RetainedEarningsAccumulatedLosses 2024-07-31 14997306 1 2024-08-01 2025-07-31 14997306 2 2024-08-01 2025-07-31 14997306 3 2024-08-01 2025-07-31 14997306 core:LandBuildings 2024-08-01 2025-07-31 14997306 core:LandBuildings 2025-07-31 14997306 core:LandBuildings 2023-07-12 2024-07-31 14997306 core:LandBuildings 2024-07-31 14997306 core:PlantMachinery 2024-08-01 2025-07-31 14997306 core:PlantMachinery 2025-07-31 14997306 core:PlantMachinery 2023-07-12 2024-07-31 14997306 core:PlantMachinery 2024-07-31 14997306 core:FurnitureFittingsToolsEquipment 2024-08-01 2025-07-31 14997306 core:FurnitureFittingsToolsEquipment 2025-07-31 14997306 core:FurnitureFittingsToolsEquipment 2023-07-12 2024-07-31 14997306 core:FurnitureFittingsToolsEquipment 2024-07-31 14997306 core:OfficeEquipment 2024-08-01 2025-07-31 14997306 core:OfficeEquipment 2025-07-31 14997306 core:OfficeEquipment 2023-07-12 2024-07-31 14997306 core:OfficeEquipment 2024-07-31 14997306 core:Vehicles 2024-08-01 2025-07-31 14997306 core:Vehicles 2025-07-31 14997306 core:Vehicles 2023-07-12 2024-07-31 14997306 core:Vehicles 2024-07-31 14997306 core:NetGoodwill 2024-08-01 2025-07-31 14997306 core:NetGoodwill 2025-07-31 14997306 core:NetGoodwill 2023-07-12 2024-07-31 14997306 core:NetGoodwill 2024-07-31 14997306 core:IntangibleAssetsOtherThanGoodwill 2024-08-01 2025-07-31 14997306 core:IntangibleAssetsOtherThanGoodwill 2025-07-31 14997306 core:IntangibleAssetsOtherThanGoodwill 2023-07-12 2024-07-31 14997306 core:IntangibleAssetsOtherThanGoodwill 2024-07-31

# QAMCA UK C.I.C.

## Company limited by guarantee

## Company Registration Number:
14997306 (England and Wales)

## Unaudited statutory accounts for the year ended 31 July 2025

## Period of accounts

## Start date: 1 August 2024

## End date: 31 July 2025

# QAMCA UK C.I.C.

## Contents of the Financial Statements

for the Period Ended 31 July 2025

Directors report |
Profit and loss |
Balance sheet |
Additional notes |
Community Interest Report |

# QAMCA UK C.I.C.

Directors' report period ended 31 July 2025

The directors present their report with the financial statements of the company for the period ended 31 July 2025

Principal activities of the company

The company's principal activity during the year continued to be Educational support services, social work activities without accommodation for the elderly and disabled

Directors

The director shown below has held office during the whole of the period from
1 August 2024 to 31 July 2025

AMMAR AHMAD

The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
9 July 2026

And signed on behalf of the board by:
Name: AMMAR AHMAD
Status: Director

# QAMCA UK C.I.C.

## Profit And Loss Account

for the Period Ended 31 July 2025

| 2025 | 13 months to 31 July 2024
--- | --- | ---
| £ | £
Turnover: |  | 10,275
Cost of sales: | ( 6,445 ) | ( 2,353 )
Gross profit(or loss): | (6,445) | 7,922
Administrative expenses: | ( 900 ) | ( 3,000 )
Operating profit(or loss): | (7,345) | 4,922
Profit(or loss) before tax: | (7,345) | 4,922
Profit(or loss) for the financial year: | (7,345) | 4,922

# QAMCA UK C.I.C.

## Balance sheet

As at 31 July 2025

| Notes | 2025 | 13 months to 31 July 2024
--- | --- | --- | ---
|  | £ | £
Current assets
Cash at bank and in hand: |  | 1,476 | 7,922
Total current assets: |  | 1,476 | 7,922
Net current assets (liabilities): |  | 1,476 | 7,922
Total assets less current liabilities: |  | 1,476 | 7,922
Provision for liabilities: |  | ( 3,900 ) | ( 3,000 )
Total net assets (liabilities): |  | (2,424) | 4,922
Members' funds
Profit and loss account: |  | (2,424) | 4,922
Total members' funds: |  | ( 2,424) | 4,922

The notes form part of these financial statements

# QAMCA UK C.I.C.

## Balance sheet statements

For the year ending 31 July 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 9 July 2026
and signed on behalf of the board by:

Name: AMMAR AHMAD
Status: Director

The notes form part of these financial statements

# QAMCA UK C.I.C.

## Notes to the Financial Statements

for the Period Ended 31 July 2025

- ## 1. Accounting policies

  Basis of measurement and preparation

  These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

# QAMCA UK C.I.C.

## Notes to the Financial Statements

for the Period Ended 31 July 2025

- ## 2. Employees

  | 2025 | 13 months to 31 July 2024
  --- | --- | ---
  Average number of employees during the period | 0 | 0

# COMMUNITY INTEREST ANNUAL REPORT

### QAMCA UK C.I.C.

### Company Number: 14997306 (England and Wales)

### Year Ending: 31 July 2025

Company activities and impact

The medical community, particularly medical students and trainee clinicians who need assistance, will be our focus. Our initial efforts will take place at Quaid-e-Azam Medical College and Bahawal Victoria Hospital in Bahawalpur, with the possibility of expanding to neighbouring areas in the future. Senior doctors and clinicians will also be invited to join our organization as donors or trustees. Our board is composed of founding members who have agreed to work on a voluntary basis, and who will not receive compensation from collected funds or donations. These members have expressed their long-term commitment to promoting diversity, transparency, and accountability. Our organization's goals, objectives, and activities will be closely monitored through a long-term strategy designed to strengthen our educational and development initiatives, as well as our campaigns to coordinate and collaborate with our board members and donors. We are eager to collaborate with the Quaid-e-Azam Medical College Alumni Organization, as well as other organizations located within the medical institute, to promote our activities and support the medical community.

Consultation with stakeholders

Evidence for community funding can be provided through regular reporting and updates from project leads. This can include detailed financial reports, progress updates, and impact assessments. Additionally, we can provide testimonials and feedback from members of the medical community who have directly benefited from our funding and resources. We also have a dedicated team responsible for monitoring the use of funds and resources allocated to various projects, ensuring that they align with our objectives and deliver maximum impact to our community. Our commitment to transparency, accountability, and good governance is an integral part of our monitoring policy and is reflected in all aspects of our work.

Directors' remuneration

No remuneration was received

Transfer of assets

No transfer of assets other than for full consideration

This report was approved by the board of directors on
9 July 2026

And signed on behalf of the board by:
Name: AMMAR AHMED
Status: Director